GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

Mean and standard deviation values for the Impulse during the first 50 ms of stance (Imp50) during running shod (SH) and barefoot (BF), in both PRE and POST training, where (<sup>a... by Ana Paula da Silva Azevedo (3373688)

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Subjects:

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in the embryonic neocortex. by Ryohei Minamide (505053)

Subjects:

Gradual decreases in tyrosinase expression detected by Western blotting. by Shuji Nakamura (230936)

Simulation results for neurons with decreasing output firing rate. by Jing Kang (251503)

Exposure of HOB to chemotherapeutic agents or rTGF-β1 diminished the ability of HOB to support human embryonic stem cells and decreased pro-B cell interaction with HOB. by Stephanie L. Rellick (182765)

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Overexpression of PDE7B increases stem cell fraction and accelerates in vivo tumor growth and decreases survival. by Michael D. Brooks (627532)

“…<p>(<b>A</b>) Frequency of clonogenic stem-like cells as determined by Extreme Limiting Dilution Assays (ELDA) with U87 cells expressing PDE7B (WT), catalytically inactive PDE7B (H217Q) or no vector control (U87GL). …”

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

Loss of Arid3b in Bone Marrow Results in Decreased B cells. by Jeffrey L. Kurkewich (3044211)

Subjects:

UCHL1 depletion decreases Wnt signaling activity. by Patricia C. Sanchez-Diaz (403746)

The frequency of decrease in UACR and UPCR at 16 weeks as secondary outcomes. by Yong-Chul Kim (1637572)

“…Outcome Ba and Bp: frequency of decrease in UACR and UPCR ≥50% at 16 weeks compared to baseline level, Outcome Ca and Cp: frequency of decrease in UACR and UPCR <200 mg/g cr at 16 weeks. …”

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”

Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5). by Tingting Liu (267387)

“…</p><p>Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5).…”

Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

Subjects: